TrialJournal of hypertension2019

Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuria.

Mark E Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.